Cancer-testis antigen MAGE-C2 binds Rbx1 and inhibits ubiquitin ligase-mediated turnover of cyclin E

Jiaqing Hao, Xiao Song, Jingjing Wang, Chengli Guo, Yan Li, Bing Li, Yu Zhang*, Yanhui Yin

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Abstract

Cancer-testis antigen MAGE-C2 is normally expressed in testis but aberrantly expressed in various kinds of tumors. Its functions in tumor cells are mostly unknown. Here, we show that MAGE-C2 binds directly to the RING domain protein Rbx1, and participates in Skp1-Cullin1-F box protein (SCF) complex. Furthermore, MAGE-C2 can inhibit the E3 ubiquitin ligase activity of SCF complex. Ablation of endogenous MAGE-C2 decreases the level of cyclin E and accelerates cyclin E turnover by inhibiting ubiquitin-mediated proteasome degradation. Overexpression of MAGE-C2 increases the level of cyclin E and promotes G1-S transition and cell proliferation, and the results are further confirmed by knockdown of MAGE-C2. Overall, the study indicates that MAGE-C2 is involved in SCF complex and increases the stability of cyclin E in tumor cells.

Original languageEnglish (US)
Pages (from-to)42028-42039
Number of pages12
JournalOncotarget
Volume6
Issue number39
DOIs
StatePublished - 2015

Keywords

  • Cancer-testis antigen
  • Cell cycle
  • Cyclin E
  • MAGE-C2
  • SCF complex

ASJC Scopus subject areas

  • Oncology

Fingerprint

Dive into the research topics of 'Cancer-testis antigen MAGE-C2 binds Rbx1 and inhibits ubiquitin ligase-mediated turnover of cyclin E'. Together they form a unique fingerprint.

Cite this